Invest now
Vivanza Biosciences share price
High risk
You have to be logged in to add this to Watchlist.- ₹1.90(-4.52%)August 14, 2026 15:15:00 PM IST
- NSE
- BSE
- Vol : 28.10 K (NSE + BSE)Last 20 day avg : 14.92 K
Vivanza Biosciences is trading -4.52% lower at Rs 1.90 as compared to its last closing price. Vivanza Biosciences has been trading in the price range of 1.90 & 1.65. Vivanza Biosciences has given -9.55% in this year & 5.29% in the last 5 days. The company posted a net profit of 0.15 Crores in its last quarter.Listed peers of Vivanza Biosciences include Sun Pharmaceutical Industries (-0.92%), Divi's Laboratories (-%), Torrent Pharmaceuticals (-0.74%).The Mutual Fund holding in Vivanza Biosciences was at -% in . The MF holding has - from the last quarter. The FII holding in Vivanza Biosciences was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 16 Aug 2026, 04:55 PM IST
- BetaLow volatility0.32Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-1.32The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Vivanza Biosciences Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,924.90 | -0.92 | 4,61,837.11 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 8,500.00 | - | 2,25,648.29 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,840.30 | -0.74 | 1,84,109.45 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,450.00 | -0.75 | 1,17,138.71 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,140.00 | -2.81 | 1,13,715.44 | 21.19 | 4.24 | 0.09 | 14.22 |
Vivanza Biosciences Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-17 | Others |
| 2026-08-07 | Quarterly Results |
| 2026-08-01 | Quarterly Results |
| 2026-06-18 | Others |
| 2026-05-07 | Audited Results |
About the company Vivanza Biosciences
- IndustryBiotechnology & Drugs
- ISININE984E01035
- BSE Code530057
- NSE Code
Vivanza Biosciences Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of pharmaceutical products. Its products include gloves and surgical. Its Gloves products include latex examination gloves powdered, latex surgical powder free, latex free examination gloves-vinyl, latex free examination gloves-nitrile, and latex surgical powdered. The Company’s products catalogues include Injectable Products, Vivanza Gloves, Therapeutic Index Injection, Veterinary Product, and Veterinary Feed. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.
Vivanza Biosciences Share Price FAQs
Vivanza Biosciences is trading at 1.90 as on Fri Aug 14 2026 09:45:00. This is -4.52% lower as compared to its previous closing price of 1.99.
The market capitalization of Vivanza Biosciences is 7.60 Cr as on Fri Aug 14 2026 09:45:00.
The 52 wk high for Vivanza Biosciences is 2.72 whereas the 52 wk low is 1.52
Vivanza Biosciences can be analyzed on the following key metrics -
- TTM P/E: 15.17
- Sector P/E: -
- Dividend Yield: 0.00%
- D/E ratio: -
Vivanza Biosciences reported a net profit of 0.39 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Vivanza Biosciences QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.